share_log

Nexalin Technology Announces Abstract Accepted For Presentation At 2023 Military Health System Research Symposium Validating The Potential Of Its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device For The Treatment Of Mild Traumatic Brain Injury

Benzinga ·  Jul 10, 2023 20:39

Nexalin Technology, Inc.(the "Company" or "Nexalin")(NASDAQ:NXL, NXLIW)today announced that Company's abstract, titled: "MEG Source Imaging Reveals Neuronal Changes in Combat-Related Mild Traumatic Brain Injury after Transcranial Electrical Stimulation using Nexalin," has been accepted for a poster presentation at the upcoming 2023 Military Health System Research Symposium (MHSRS) being held on August 14-17, 2023 at the Gaylord Palms Resort and Convention Center, Kissimmee, Florida, USA.

The abstract was accepted under the breakout session: Mental Health and Traumatic Brain Injury. The poster for this breakout session will be presented in Poster Session 2 on Tuesday, August 15, 2023. The poster will be...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment